RecruitingPhase 4NCT06991972

Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients

Puncture to Repigment: A Comparative Analysis Of Needling vs. Microneedling Along With NBUVB in Treatment of Non-Segmental Vitiligo


Sponsor

Khyber Teaching Hospital

Enrollment

80 participants

Start Date

Mar 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized controlled trial aims to compare the efficacy of needling versus microneedling, both followed by narrowband UVB therapy, in achieving repigmentation in patients with localized stable non-segmental vitiligo.


Eligibility

Min Age: 15 YearsMax Age: 60 Years

Inclusion Criteria3

  • Both male and female
  • Age 15-60 years
  • Patients having vitiligo for more than 1 year

Exclusion Criteria4

  • Patients with tendency of keloid formation or hypertrophic scarring
  • Patients with any bleeding disorder, coagulation defect or using anti platelets
  • Any local infection at the treatment site
  • Patients who had received systemic therapy in last 6 months

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURENeedling + NBUVB

Participants in this arm will undergo needling using a sterile 30G (4mm) needle to manually puncture and implant melanocytes from perilesional pigmented skin into depigmented lesions. The procedure will be performed once every four weeks for a total of six sessions.

PROCEDUREMicroneedling + NBUVB

Participants in this arm will undergo microneedling using a Dermapen device with 1.5 mm needles to create controlled micro-injuries in depigmented skin to enhance melanocyte migration and repigmentation. This procedure will be performed once every four weeks for six sessions.


Locations(1)

Khyber Teaching Hospital

Peshawar, Khyber Pakhtunkhwa, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06991972


Related Trials